Literature DB >> 9110979

Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation.

Y Lin1, K Wong, K Calame.   

Abstract

Transcription of c-myc in plasma cells, which are terminally differentiated B cells, is repressed by plasmacytoma repressor factor. This factor was identified as Blimp-1, known for its ability to induce B cell differentiation. Blimp-1 repressed c-myc promoter activity in a binding site-dependent manner. Treatment of BCL1 lymphoma cells with interleukin-2 (IL-2) plus IL-5 induced Blimp-1 and caused a subsequent decline in c-Myc protein. Ectopic expression of Blimp-1 in Abelson-transformed precursor B cells repressed endogenous c-Myc and caused apoptosis; Blimp-1-induced death was partially overcome by ectopic expression of c-Myc. Thus, repression of c-myc is a component of the Blimp-1 program of terminal B cell differentiation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9110979     DOI: 10.1126/science.276.5312.596

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  145 in total

1.  Identification of a zinc finger protein whose subcellular distribution is regulated by serum and nerve growth factor.

Authors:  A Chittka; M V Chao
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

2.  Regulated subset of G1 growth-control genes in response to derepression by the Wnt pathway.

Authors:  Sung Hee Baek; Chrissa Kioussi; Paola Briata; Degeng Wang; H D Nguyen; Kenneth A Ohgi; Christopher K Glass; Anthony Wynshaw-Boris; David W Rose; Michael G Rosenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

3.  PRDM1 is required for mantle cell lymphoma response to bortezomib.

Authors:  Shruti Desai; Michelle Maurin; Matthew A Smith; Sophia C E Bolick; Sophie Dessureault; Jianguo Tao; Eduardo Sotomayor; Kenneth L Wright
Journal:  Mol Cancer Res       Date:  2010-06-08       Impact factor: 5.852

4.  Repression of c-Myc and inhibition of G1 exit in cells conditionally overexpressing p300 that is not dependent on its histone acetyltransferase activity.

Authors:  Sudhakar Baluchamy; Hasan N Rajabi; Rama Thimmapaya; Arunasalam Navaraj; Bayar Thimmapaya
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-25       Impact factor: 11.205

5.  PRDM1 is a tumor suppressor gene in natural killer cell malignancies.

Authors:  Can Küçük; Javeed Iqbal; Xiaozhou Hu; Phillip Gaulard; Laurence De Leval; Gopesh Srivastava; Wing Yan Au; Timothy W McKeithan; Wing C Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

6.  Blimp1 suppresses Chx10 expression in differentiating retinal photoreceptor precursors to ensure proper photoreceptor development.

Authors:  Kimiko Katoh; Yoshihiro Omori; Akishi Onishi; Shigeru Sato; Mineo Kondo; Takahisa Furukawa
Journal:  J Neurosci       Date:  2010-05-12       Impact factor: 6.167

Review 7.  Oncogenic activation of NF-kappaB.

Authors:  Louis M Staudt
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-04-21       Impact factor: 10.005

8.  Blimp-1/PRDM1 mediates transcriptional suppression of the NLR gene NLRP12/Monarch-1.

Authors:  Christopher A Lord; David Savitsky; Raquel Sitcheran; Kathryn Calame; Jo Rae Wright; Jenny Pan-Yun Ting; Kristi L Williams
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

Review 9.  The biology of human lymphoid malignancies revealed by gene expression profiling.

Authors:  Louis M Staudt; Sandeep Dave
Journal:  Adv Immunol       Date:  2005       Impact factor: 3.543

10.  The Blimp-1 gene regulatory region directs EGFP expression in multiple hematopoietic lineages and testis in mice.

Authors:  Dingyan Wang; Lihua Zhuang; Bo Gao; Chang-Xin Shi; Joseph Cheung; Mingyao Liu; Tianru Jin; Xiao-Yan Wen
Journal:  Transgenic Res       Date:  2007-09-19       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.